Episodic, intensive SMBG in non-insulin-treated T2DM: can this form of patient-provided data be trusted?

被引:0
|
作者
Polonsky, W. [1 ]
Fisher, L. [2 ]
Parkin, C. [3 ]
Jelsovsky, Z. [4 ]
Wagner, R. [5 ]
机构
[1] Behav Diabet Inst, San Diego, CA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] CGParkin Commun Inc, Las Vegas, NV USA
[4] Biostat Int Inc, Tampa, FL USA
[5] Roche Diagnost Inc, Indianapolis, IN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
962
引用
收藏
页码:S392 / S392
页数:1
相关论文
共 12 条
  • [1] Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention
    Scavini, Marina
    Bosi, Emanuele
    Ceriello, Antonio
    Giorgino, Francesco
    Porta, Massimo
    Tiengo, Antonio
    Vespasiani, Giacomo
    Bottalico, Davide
    Marino, Raffaele
    Parkin, Christopher
    Bonizzoni, Erminio
    Cucinotta, Domenico
    [J]. ACTA DIABETOLOGICA, 2013, 50 (05) : 663 - 672
  • [2] Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention
    Marina Scavini
    Emanuele Bosi
    Antonio Ceriello
    Francesco Giorgino
    Massimo Porta
    Antonio Tiengo
    Giacomo Vespasiani
    Davide Bottalico
    Raffaele Marino
    Christopher Parkin
    Erminio Bonizzoni
    Domenico Cucinotta
    [J]. Acta Diabetologica, 2013, 50 : 663 - 672
  • [3] Added value of intensive structured SMBG. Study in non-insulin-treated Type 2 Diabetes Patients
    Jecht, M.
    [J]. DIABETOLOGE, 2013, 9 (07): : 559 - 560
  • [4] Structured SMBG Promotes Positive Changes in Self-Management Attitudes in Non-Insulin Treated T2DM: STeP Study Results
    Fisher, Lawrence
    Polonsky, William
    Parkin, Christopher
    Jelsovsky, Zhihong
    Wagner, Robin
    [J]. DIABETES, 2011, 60 : A111 - A112
  • [5] MODELING THE HEALTH AND ECONOMIC CONSEQENCES OF SELF-MONITORING OF BLOOD GLUCOSE (SMBG) IN NON-INSULIN TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN SPAIN
    Dirani, R.
    Diago-Cabezudo, J., I
    Willis, W.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A354 - A354
  • [6] Optimizing Glycemic Control in T2DM Patients Previously Treated With Intensive Insulin Therapy and Switched to Exenatide-Insulin Glargine Combination
    Avramidis, Iakovos
    Spyridonidou, Christina
    Stoimenis, Dimitris
    Lalia, Antigoni
    [J]. DIABETES, 2013, 62 : A261 - A261
  • [7] First French study on the determinants of the acceptability and prescription of self-monitoring blood glucose (SMBG) by GPs in diabetic type 2 non-insulin-treated (T2D-NI)
    Halimi, S.
    Studer, N.
    David-Tchouda, S.
    Bosson, J. -L.
    Egea, M.
    Boizel, R.
    [J]. DIABETES & METABOLISM, 2012, 38 : A58 - A58
  • [8] Primary Care Physicians Identify and Act upon Glycemic Abnormalities Found in Structured, Episodic Blood Glucose Monitoring Data from Non-Insulin-Treated Type 2 Diabetes
    Polonsky, William H.
    Jelsovsky, Zhihong
    Panzera, Susanne
    Parkin, Christopher G.
    Wagner, Robin S.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (05) : 283 - 291
  • [9] Predictors of good glycaemic control in Chinese T2DM patients treated with biphasic insulin aspart 30:Data from the A1chieve study
    石勇铨
    [J]. China Medical Abstracts (Internal Medicine), 2017, 34 (02) : 92 - 93
  • [10] NEW META-ANALYSIS OF PATIENT-LEVEL DATA ON EFFICACY AND HYPOGLYCAEMIA WITH INSULIN GLARGINE OR NPH INSULIN IN TYPE 2 DIABETES MELLITUS (T2DM) ACCORDING TO CONCOMITANT ORAL THERAPY
    Owens, D. R.
    Trayor, L.
    Landgraf, W.
    Mullins, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A335 - A335